In Western countries gastric cancer is commonly diagnosed in locally advanced stages. Although locally advanced gastric cancer is still a potentially curable disease, the prognosis is poor and surgery as first approach does not represent the best option. In order to improve survival, today the management of locally advanced gastric cancer is based on a multimodal treatment, including surgery with extended lymphadenectomy and effective chemotherapeutic schedules. The multimodal approach in gastric cancer aims to provide successful combination and cooperation between surgery and medical treatment: today there is current evidence supporting the use of systemic chemotherapy in a perioperative setting. The role of chemotherapy in gastric cancer is constantly evolving in order to improve outcomes and to reduce therapyassociated toxicity. In this paper we analyze the multidisciplinary approach in the treatment of locally advanced gastric cancer, particularly focusing on the surgeon’s role in this setting.

Neoadjuvant chemotherapy for locally advanced gastric cancer: the surgeon’s role / S. Sebastiano, R. Stefano, G. Federica, R. Laura, P. Chiara, F. Francesco, R. Francesca, L. Boni, G. Dionigi. - In: TRANSLATIONAL GASTROINTESTINAL CANCER. - ISSN 2224-476X. - 4:2(2015), pp. 141-147. [10.3978/j.issn.2224-4778.2014.12.02]

Neoadjuvant chemotherapy for locally advanced gastric cancer: the surgeon’s role

L. Boni;G. Dionigi
2015

Abstract

In Western countries gastric cancer is commonly diagnosed in locally advanced stages. Although locally advanced gastric cancer is still a potentially curable disease, the prognosis is poor and surgery as first approach does not represent the best option. In order to improve survival, today the management of locally advanced gastric cancer is based on a multimodal treatment, including surgery with extended lymphadenectomy and effective chemotherapeutic schedules. The multimodal approach in gastric cancer aims to provide successful combination and cooperation between surgery and medical treatment: today there is current evidence supporting the use of systemic chemotherapy in a perioperative setting. The role of chemotherapy in gastric cancer is constantly evolving in order to improve outcomes and to reduce therapyassociated toxicity. In this paper we analyze the multidisciplinary approach in the treatment of locally advanced gastric cancer, particularly focusing on the surgeon’s role in this setting.
Adjuvant therapy; chemotherapy; gastric cancer; multimodal treatment; neoadjuvant therapy
Settore MED/18 - Chirurgia Generale
22-dic-2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
5474-PB2-R2.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 187.08 kB
Formato Adobe PDF
187.08 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/887390
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 2
social impact